Reuters logo
BRIEF-Sage Therapeutics announces qtrly loss per share $1.97‍​
November 2, 2017 / 10:34 AM / 23 days ago

BRIEF-Sage Therapeutics announces qtrly loss per share $1.97‍​

Nov 2 (Reuters) - Sage Therapeutics Inc

* Sage Therapeutics announces third quarter 2017 financial results and provides pipeline update

* Qtrly loss per share $1.97‍​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below